The purpose of this article was to demonstrate the application of a new thermogelling matrix in the healing of wounds.
This work focuses on the preparation, characterization, and evaluation of a thermogelling matrix of Pluronic F-127 containing elastic liposomes loaded with a platelet lysate and which is intended for healing wounds. In this study, elastic liposomes were characterized, and their biological activity was confirmed. Liposomes were obtained that had a high encapsulation rate. The formulation of liposomes in a thermogelling matrix based on Pluronic F-127 improved the properties of the product, favoring its application and retention on the skin, and promoting tissue regeneration, both on a culture of fibroblasts, and in vivo in mice. The results showed that this system is a potentially good alternative for the treatment of wounds based on its ability to protect the platelet lysate, allow its gradual release, produce a semi-occlusive effect on the skin, and promote fast tissue regeneration.
Click here for a PDF of this article.Submitted: Feb. 21, 2022
Accepted: June 9, 2022
Sergio A. Bernal-Chávez, PhD, is research associate, and Adriana Ganem-Rondero*, PhD, ganemq@hotmail.com, is principal scientist; both at Laboratorio de Investigación y Posgrado en Tecnología Farmacéutica (L-322, Campo 1), Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México; Sergio Alcalá-Alcalá, PhD, is principal scientist at Laboratorio de Tecnología Farmacéutica, Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México; and Doris Cerecedo, PhD, is principal scientist at Laboratorio de Hematobiología, Escuela Nacional de Medicina y Homeopatía, Sección de Estudios de Posgrado, Instituto Politécnico Nacional, Ciudad de México.
*To whom all correspondence should be addressed.
Pharmaceutical Technology
Vol. 46, No. 8
August 2022
Pages: 35–41
When referring to this article, please cite it as S.A. Bernal-Chávez, et al., “Thermogelling Matrix-Containing Platelet Lysate-Loaded Elastic Liposomes as a Potential Treatment of Wounds,” Pharmaceutical Technology 46 (8) 35–41 (2022).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.